1. Efficacy and Safety of Sofosbuvir/Velpatasvir/Voxilaprevir for Hepatitis C Virus (HCV) NS5A-Inhibitor Experienced Patients With Difficult to Cure Characteristics. (5th September 2020) Authors: Papaluca, Timothy; Roberts, Stuart K; Strasser, Simone I; Stuart, Katherine A; Farrell, Geoffrey; MacQuillan, Gerry; Dore, Gregory J; Wade, Amanda J; George, Jacob; Hazeldine, Simon; O'Beirne, James; Wigg, Alan; Fisher, Leslie; McGarity, Bruce; Sawhney, Rohit; Sinclair, Marie; Thomas, James; Vali... Journal: Clinical infectious diseases Issue: Volume 73:Number 9(2021) Page Start: e3288 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗